α-Conotoxin PnIASelective α3β2 nAChR antagonist CAS# 705300-84-1 |
- Dihydroberberine
Catalog No.:BCN2573
CAS No.:483-15-8
- Pectolinarigenin
Catalog No.:BCN5813
CAS No.:520-12-7
- Carnosol
Catalog No.:BCN1055
CAS No.:5957-80-2
- Hypaconine
Catalog No.:BCN8640
CAS No.:63238-68-6
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 705300-84-1 | SDF | Download SDF |
PubChem ID | 73755066 | Appearance | Powder |
Formula | C65H95N19O22S4 | M.Wt | 1622.82 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 5 mg/ml in water | ||
Sequence | GCCSLPPCAANNPDYC (Modifications: Cys-16 = C-terminal amide, Disulfide bridge between 2 - 8, 3 - 16) | ||
Chemical Name | 2-[(1R,6R,9S,12S,15S,21S,24S,27S,30S,33R,36S,42S,48S,51S,56R)-56-[(2-aminoacetyl)amino]-21,24-bis(2-amino-2-oxoethyl)-6-carbamoyl-51-(hydroxymethyl)-9-[(4-hydroxyphenyl)methyl]-27,30-dimethyl-48-(2-methylpropyl)-8,11,14,20,23,26,29,32,35,41,47,50,53,55-tetradecaoxo-3,4,58,59-tetrathia-7,10,13,19,22,25,28,31,34,40,46,49,52,54-tetradecazapentacyclo[31.20.7.015,19.036,40.042,46]hexacontan-12-yl]acetic acid | ||
SMILES | CC1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(CSSCC3C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CSSCC(C(=O)N3)NC(=O)CN)C(=O)NC(C(=O)N1)C)CC(C)C)CO)C(=O)N)CC6=CC=C(C=C6)O)CC(=O)O)CC(=O)N)CC(=O)N | ||
Standard InChIKey | VUVGEYBNLLGGBG-MVPSLEAZSA-N | ||
Standard InChI | InChI=1S/C65H95N19O22S4/c1-29(2)18-37-63(104)84-17-7-10-46(84)65(106)83-16-6-9-45(83)62(103)81-42-27-110-108-26-41(72-49(89)23-66)59(100)80-43(60(101)78-39(24-85)57(98)76-37)28-109-107-25-40(51(69)92)79-54(95)34(19-32-11-13-33(86)14-12-32)74-56(97)36(22-50(90)91)75-61(102)44-8-5-15-82(44)64(105)38(21-48(68)88)77-55(96)35(20-47(67)87)73-53(94)31(4)70-52(93)30(3)71-58(42)99/h11-14,29-31,34-46,85-86H,5-10,15-28,66H2,1-4H3,(H2,67,87)(H2,68,88)(H2,69,92)(H,70,93)(H,71,99)(H,72,89)(H,73,94)(H,74,97)(H,75,102)(H,76,98)(H,77,96)(H,78,101)(H,79,95)(H,80,100)(H,81,103)(H,90,91)/t30-,31-,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Selective antagonist of α3β2 nAChR receptors (IC50 values are 9.56 and 252 nM for α3β2 and α7 receptors respectively). |
α-Conotoxin PnIA Dilution Calculator
α-Conotoxin PnIA Molarity Calculator
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 3,5-Dimethoxybenzylalcohol
Catalog No.:BCN3760
CAS No.:705-76-0
- 2'-Hydroxy-5'-methoxyacetophenone
Catalog No.:BCN4270
CAS No.:705-15-7
- ARP 100
Catalog No.:BCC2370
CAS No.:704888-90-4
- Mitoxantrone HCl
Catalog No.:BCC4924
CAS No.:70476-82-3
- Petasinoside
Catalog No.:BCN1989
CAS No.:70474-34-9
- Petasinine
Catalog No.:BCN1988
CAS No.:70474-33-8
- Schizanthine A
Catalog No.:BCN1936
CAS No.:70474-24-7
- Corymbol
Catalog No.:BCN6617
CAS No.:7047-54-3
- Norfloxacin
Catalog No.:BCC4688
CAS No.:70458-96-7
- Pefloxacin Mesylate
Catalog No.:BCC4821
CAS No.:70458-95-6
- Pefloxacin
Catalog No.:BCC4231
CAS No.:70458-92-3
- (+)-MK 801
Catalog No.:BCC1288
CAS No.:70449-94-4
- NS 3763
Catalog No.:BCC7275
CAS No.:70553-45-6
- Aflatrem
Catalog No.:BCN7414
CAS No.:70553-75-2
- Daurisoline
Catalog No.:BCN2675
CAS No.:70553-76-3
- Herbimycin A
Catalog No.:BCC7132
CAS No.:70563-58-5
- Yunaconitine
Catalog No.:BCN6261
CAS No.:70578-24-4
- Shizukanolide A
Catalog No.:BCN8021
CAS No.:70578-36-8
- Obtusin
Catalog No.:BCC8223
CAS No.:70588-05-5
- Chrysoobtusin
Catalog No.:BCC8309
CAS No.:70588-06-6
- 19alpha-Hydroxyfern-7-ene
Catalog No.:BCN7405
CAS No.:70588-12-4
- 14beta-Benzoyloxy-2-deacetylbaccatin VI
Catalog No.:BCN1373
CAS No.:705973-69-9
- Phlorizin dihydrate
Catalog No.:BCN2584
CAS No.:7061-54-3
- Boc-D-Tyr-OH
Catalog No.:BCC3463
CAS No.:70642-86-3
High-Affinity alpha-Conotoxin PnIA Analogs Designed on the Basis of the Protein Surface Topography Method.[Pubmed:27841338]
Sci Rep. 2016 Nov 14;6:36848.
Despite some success for small molecules, elucidating structure-function relationships for biologically active peptides - the ligands for various targets in the organism - remains a great challenge and calls for the development of novel approaches. Some of us recently proposed the Protein Surface Topography (PST) approach, which benefits from a simplified representation of biomolecules' surface as projection maps, which enables the exposure of the structure-function dependencies. Here, we use PST to uncover the "activity pattern" in alpha-conotoxins - neuroactive peptides that effectively target nicotinic acetylcholine receptors (nAChRs). PST was applied in order to design several variants of the alpha-conotoxin PnIA, which were synthesized and thoroughly studied. Among the best was PnIA[R9, L10], which exhibits nanomolar affinity for the alpha7 nAChR, selectivity and a slow wash-out from this target. Importantly, these mutations could hardly be delineated by "standard" structure-based drug design. The proposed combination of PST with a set of experiments proved very efficient for the rational construction of new bioactive molecules.
Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an alpha-conotoxin PnIA variant.[Pubmed:15951818]
Nat Struct Mol Biol. 2005 Jul;12(7):582-8.
Conotoxins (Ctx) form a large family of peptide toxins from cone snail venoms that act on a broad spectrum of ion channels and receptors. The subgroup alpha-Ctx specifically and selectively binds to subtypes of nicotinic acetylcholine receptors (nAChRs), which are targets for treatment of several neurological disorders. Here we present the structure at a resolution of 2.4 A of alpha-Ctx PnIA (A10L D14K), a potent blocker of the alpha(7)-nAChR, bound with high affinity to acetylcholine binding protein (AChBP), the prototype for the ligand-binding domains of the nAChR superfamily. Alpha-Ctx is buried deep within the ligand-binding site and interacts with residues on both faces of adjacent subunits. The toxin itself does not change conformation, but displaces the C loop of AChBP and induces a rigid-body subunit movement. Knowledge of these contacts could facilitate the rational design of drug leads using the Ctx framework and may lead to compounds with increased receptor subtype selectivity.
Hydrophobic residues at position 10 of alpha-conotoxin PnIA influence subtype selectivity between alpha7 and alpha3beta2 neuronal nicotinic acetylcholine receptors.[Pubmed:25101833]
Biochem Pharmacol. 2014 Oct 15;91(4):534-42.
Neuronal nicotinic acetylcholine receptors (nAChRs) are a diverse class of ligand-gated ion channels involved in neurological conditions such as neuropathic pain and Alzheimer's disease. alpha-Conotoxin [A10L]PnIA is a potent and selective antagonist of the mammalian alpha7 nAChR with a key binding interaction at position 10. We now describe a molecular analysis of the receptor-ligand interactions that determine the role of position 10 in determining potency and selectivity for the alpha7 and alpha3beta2 nAChR subtypes. Using electrophysiological and radioligand binding methods on a suite of [A10L]PnIA analogs we observed that hydrophobic residues in position 10 maintained potency at both subtypes whereas charged or polar residues abolished alpha7 binding. Molecular docking revealed dominant hydrophobic interactions with several alpha7 and alpha3beta2 receptor residues via a hydrophobic funnel. Incorporation of norleucine (Nle) caused the largest (8-fold) increase in affinity for the alpha7 subtype (Ki=44nM) though selectivity reverted to alpha3beta2 (IC50=0.7nM). It appears that the placement of a single methyl group determines selectivity between alpha7 and alpha3beta2 nAChRs via different molecular determinants.
Identification of residues that confer alpha-conotoxin-PnIA sensitivity on the alpha 3 subunit of neuronal nicotinic acetylcholine receptors.[Pubmed:12734390]
J Pharmacol Exp Ther. 2003 Aug;306(2):664-70.
Neuronal nicotinic receptors composed of the alpha3 and beta2 subunits are at least 1000-fold more sensitive to blockade by alpha-conotoxin-PnIA than are alpha2beta2 receptors. A series of chimeric subunits, formed from portions of alpha2 and alpha3, were coexpressed with beta2 in Xenopus oocytes and tested for toxin sensitivity. We found determinants of toxin sensitivity to be widely distributed in the extracellular domain of alpha3. Analysis of receptors formed by a series of mutant alpha3 subunits, in which residues that differ between alpha3 and alpha2 were changed from what occurs in alpha3 to what occurs in alpha2, allowed identification of three determinants of alpha-conotoxin-PnIA sensitivity: proline 182, isoleucine 188, and glutamine 198. Comparison with determinants of alpha-conotoxin-MII and kappa-bungarotoxin sensitivity on the alpha3 subunit revealed overlapping, but distinct, arrays of determinants for each of these three toxins. When tested against an EC50 concentration of acetylcholine, the IC50 for alpha-conotoxin-PnIA blockade was 25 +/- 4 nM for alpha3beta2, 84 +/- 7 nM for alpha3P182Tbeta2, 700 +/- 92 nM for alpha3I188Kbeta2, and 870 +/- 61 nM for alpha3Q198Pbeta2. To examine the location of these residues within the receptor structure, we generated a homology model of the alpha3beta2 receptor extracellular domain using the structure of the acetylcholine binding protein as a template. All three residues are located on the C-loop of the alpha3 subunit, with isoleucine 188 nearest the acetylcholine-binding pocket.
Single-residue alteration in alpha-conotoxin PnIA switches its nAChR subtype selectivity.[Pubmed:10545176]
Biochemistry. 1999 Nov 2;38(44):14542-8.
alpha-Conotoxins are disulfide-rich peptides that are competitive antagonists of nicotinic acetylcholine receptors (nAChRs). Despite their small size, different alpha-conotoxins are able to discriminate among different subtypes of mammalian nAChRs. In this report, the activity of two peptides from the venom of Conus pennaceus, alpha-conotoxins PnIA and PnIB, are examined. Although the toxins differ in only two residues, PnIA preferentially blocks alpha3beta2 nAChRs, whereas PnIB prefers the alpha7 subtype. Point mutation chimeras of these alpha-conotoxins were synthesized and their activities assessed on Xenopus oocytes expressing specific nAChRs. Change of a single residue, Ala10 to Leu, in PnIA (to form PnIA [A10L]) converts the parent peptide from alpha3beta2-preferring to alpha7-preferring; furthermore, PnIA [A10L] blocks the alpha7 receptor with an IC(50) (12.6 nM) that is lower than that of either parent peptide. Kinetic analysis indicates that differences in affinity among the analogues are primarily due to differences in off-rate, with PnIA [A10L]'s interaction with alpha7 having the smallest off-rate (k(off) = 0.17 min(-)(1)). Thermodynamic analysis indicates that Leu10 enhances the peptide's interaction with alpha7, but not alpha3beta2, receptors, whereas Ser11 (in PnIA [N11S]) reduces its affinity for both alpha7 and alpha3beta2 nAChRs.
New mollusc-specific alpha-conotoxins block Aplysia neuronal acetylcholine receptors.[Pubmed:8068627]
Biochemistry. 1994 Aug 16;33(32):9523-9.
Two mollusc-specific neurotoxic peptides from the venom of the molluscivorous snail Conus pennaceus are described. These new toxins block acetylcholine receptors (AChR) of cultured Aplysia neurons. Bath application of 0.5-1 microM toxin induces 5-10-mV membrane depolarization, which recovers to the control level within 1-3 min in the presence of the toxin. This response is blocked by 1 mM hexamethonium. Concomitantly with the transient depolarization, the toxins block approximately 90% of the depolarizing responses evoked by brief iontophoretic application of acetylcholine. The pharmacology and amino acid sequences of the toxins (alpha PnIA, GCCSLPPCAANNPDYC-NH2; alpha PnIB, GCCSLPPCALSNPDYC-NH2) enable their classification as novel alpha-conotoxins. The sequences differ from those of previously described alpha-conotoxins in a number of features, the most striking of which is the presence of a single negatively charged residue in the C-terminal loop. This loop contains a positively charged residue in piscivorous venom alpha-conotoxins. In contrast to other alpha-conotoxins, which are selective for vertebrate skeletal muscle nicotinic ACh receptors, these Conus pennaceus toxins block neuronal ACh receptors in molluscs. As such they are new probes which can be used to define subtypes of ACh receptors, and they should be useful tools in the study of structure-function relationships in ACh receptors.